J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M500295-JLR200 on October 27, 2005

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M500295-JLR200v1
47/1/123    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Srivastava, A. K.
Right arrow Articles by Baylink, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srivastava, A. K.
Right arrow Articles by Baylink, D. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 47, 123-133, January 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Identification of quantitative trait loci that regulate obesity and serum lipid levels in MRL/MpJ x SJL/J inbred mice

Apurva K. Srivastava1,*,{dagger}, Subburaman Mohan*,{dagger}, Godfred L. Masinde2, Hongrun Yu* and David J. Baylink*,{dagger}

* Musculoskeletal Disease Center, Loma Linda VA Health Care Systems, Loma Linda, CA 92357
{dagger} Department of Medicine, Loma Linda University, Loma Linda, CA 92354

Published, JLR Papers in Press, October 27, 2005.

2 Present address of Godfred L. Masinde: Long Beach Genetics-Esoterix, Rancho Dominguez, CA 90220. Back

1 To whom correspondence should be addressed. e-mail: apurva.srivastava{at}med.va.gov


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The total body fat mass and serum concentration of total cholesterol, HDL cholesterol, and triglyceride (TG) differ between standard diet-fed female inbred mouse strains MRL/MpJ (MRL) and SJL/J (SJL) by 38–120% (P < 0.01). To investigate genetic regulation of obesity and serum lipid levels, we performed a genome-wide linkage analysis in 621 MRLx SJL F2 female mice. Fat mass was affected by two significant loci, D11Mit36 [43.7 cM, logarithm of the odds ratio (LOD) 11.2] and D16Mit51 (50.3 cM, LOD 3.9), and one suggestive locus at D7Mit44 (50 cM, LOD 2.4). TG levels were affected by two novel loci at D1Mit43 (76 cM, LOD 3.8) and D12Mit201 (26 cM, LOD 4.1), and two suggestive loci on chromosomes 5 and 17. HDL and cholesterol concentrations were influenced by significant loci on chromosomes 1, 3, 5, 7, and 17 that were in the regions identified earlier for other strains of mice, except for a suggestive locus on chromosome 14 that was specific to the MRL x SJL cross. In summary, linkage analysis in MRL x SJL F2 mice disclosed novel loci affecting TG, HDL, and fat mass, a measure of obesity. Knowledge of the genes in these quantitative trait loci will enhance our understanding of obesity and lipid metabolism.

Supplementary key words body fat mass • HDL cholesterol • cholesterol • triglyceride

Abbreviations: apoA-II, apolipoprotein A-II; CVD, cardiovascular disease; LOD, logarithm of the odds ratio; QTL, quantitative trait locus; SNP, single-nucleotide polymorphism; TG, triglyceride


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cardiovascular disease (CVD) is currently the leading cause of morbidity and mortality world wide, and its incidence is likely to increase. Elevated cholesterol, especially LDL cholesterol and triglyceride (TG) levels, low HDL cholesterol levels, hypertension, type 2 diabetes, and obesity modulate risk for CVD (1, 2). Such risk factors are present in 80–90% of CVD patients. Current understanding supports a complex etiology involving both environmental and genetic determinants. Environmental risk factors for CVDs identified in humans include diet, physical activity, cigarette smoking, high blood pressure, uncontrolled diabetes, obesity and overweight, stress, and adverse lipid profile (2). However, little is known about the genetic regulation of blood lipid levels, with only some of the genes that regulate production or blood levels of lipids having so far been identified (3–9). Because of inherent difficulties in carrying out linkage analyses for complex traits in humans, inbred strains of mice have been used as a powerful tool for identifying quantitative trait loci (QTLs) that contribute to variations in circulating levels of lipids (10–29). QTL studies in mice have not only revealed a large number of loci that regulate lipid levels in blood but also have shown that there is a high degree of concordance between human QTLs that regulate lipid levels and their corresponding mouse loci (30, 31). More than 60 QTLs on chromosomes 1, 2, 3, 5, 7, 8, 9, 14, 16, 17, 18, and 19 that affect plasma lipid levels, as well as body fat mass QTLs, have been identified in several strains of mice (10–29). The rationale for using different crosses is based on the fact that each parental mouse strain represents unique mapping panels for the identification of QTLs for a complex trait. The phenotypic differences between parental strains, the extent of allelic variation, and the strain background are critical factors that determine whether a given QTL can be detected in a particular cross. This implies that a best estimate of all genes that account for a total variation of lipid levels in humans and mice can only be achieved by comparing the results of multiple crosses.

Mouse strains MRL/MpJ (MRL) and SJL/J (SJL) display extreme rates of soft-tissue healing and regeneration, and our laboratory has used these two strains in the past to reveal linkage to several loci that control soft-tissue healing (32) and musculoskeletal phenotypes (33–37). We have observed that when MRL and SJL mice are fed a standard diet, they also display large differences in serum levels of cholesterol, HDL, TG, and body fat mass. To examine the genetic basis of these differences, we measured serum levels of cholesterol, HDL, TG, and body fat mass in the F2 progeny. The aim of this study was to identify loci that regulate body fat mass, cholesterol, HDL, and TG in the F2 mice of MRL x SJL crosses. Because multiple phenotypes were measured in this study, an additional aim was to identify common loci that regulate obesity and lipid levels.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Mice
Acquisition of MRL/MpJ (MRL) and SJL/J (SJL) mice, generation of F1 and F2 progeny, collection of DNA samples, and collection and processing of blood were performed as described previously (32). In brief, MRL females were mated with SJL males to produce F1 mice. Brother-sister mating was established to produce F2 mice. Only female F2 mice were weaned onto standard diet (TD 99479; Harlan Teklad, Madison, WI) at 21 days and housed three to six animals per cage. Mice were fed standard diet up to 7 weeks of age, when they were euthanized and bled without fasting. Age-matched parent mice were purchased from the Jackson Laboratory for plasma lipid analyses. All mice were allowed free access to standard food and water throughout the course of the study.

All blood samples were collected in the afternoon at the same time of day (±2 h) under nonfasting conditions. Blood was collected directly into 1.5 ml plastic tubes (Eppendorf), and serum was separated from cells by centrifugation within 1 h of blood collection. Serum was stored at –70°C until analyzed. The experimental protocols were in compliance with animal welfare regulations and approved by the Institutional Animal Care and Use Committee, Jerry L. Pettis VA Medical Center.

Serum cholesterol, HDL, and TG measurements
Total cholesterol, HDL cholesterol, and TG were measured by direct enzymatic colorimetric assays using a fully automated Hitachi 912 Clinical Chemistry Analyzer (Roche Diagnostics; Indianapolis, IN). Measurements of cholesterol, HDL, and TG were validated in our laboratory for reproducibility and analytical recovery in mice serum. The inter-assay (n = 12) and intra-assay (n = 5) coefficients of variation for all three assays were <7%. The mean analytical recovery of the diluted mouse serum samples (n = 3; up to 4-fold) was 100.3%. The sensitivity of the cholesterol and HDL assay was 3 mg/dl, and that of the TG assay was 4 mg/dl. The measuring range for cholesterol and TG was 3–800 mg/dl. The measuring range for HDL was 3–200 mg/dl in mouse serum.

Analysis of fat mass
The percent fat mass was measured using peripheral dual-energy X-ray absorptiometry (PIXIMUS densitometer; Lunar Corp., Madison, WI), a method that has been validated for mice (14). The precision of PIXIMUS for measurement of total body fat mass is coefficient of variance <2%. The body mass index (BMI) was calculated as described previously (14).

Construction of linkage map
Extraction of genomic DNA and PCR-based genotyping with 137 microsatellite markers have been described previously (32–36). Alleles derived from the MRL/MpJ parent were designated A, SJL/J-derived alleles were designated B, and MRL/SJL heterozygotes were designated H in data analyses. Marker orders were estimated from the publicly available Mouse Genome Database. A total of 132 markers distributed across the 19 autosomes were used for statistical analyses (excluding the X-chromosome). A list of markers and the resulting linkage map are available from the authors.

Statistical analyses
Data were analyzed using GraphPad Prism (Windows version 4.02; GraphPad Software, San Diego, CA). The Shapiro-Wilk test was used to test the normality of the F2 population (32–37). One-way ANOVAs with Newman-Keuls test were used to compare pairs of data in order to determine statistically significant differences in plasma lipid levels, BMI, and percent fat between mouse groups.

Genotype data were analyzed using the Pseudomarker MAINSCAN algorithm (38) written for the MATLAB (Mathworks, Inc.; Natick, MA) programming environment (available from www.jax.org/research/churchill). Thresholds for logarithm of the odds ratio (LOD) scores for different QTLs were determined by genome-wide 1,000-permutation test for 1% genome-wide error (P < 0.01) and 5% genome-wide error (P < 0.05). Linkage analyses were also performed using MapQTL 5.0 (DLO Center for Plant Breeding and Reproduction Research; Wageningen, the Netherlands) as described for F2 intercrosses. Pseudomarker and MapQTL 5.0 analyses yielded comparable results. Percent variance explained by each locus was calculated for peak interval by MapQTL software.

To study genome-wide interactions between QTLs, we used the Pseudomarker PAIRSCAN algorithm. This program analyzes the phenotypic effect of each marker or marker interval taken singly (MAINSCAN) and also the phenotypic effects of pairs of markers or intervals taken jointly (PAIRSCAN) for their effects on the trait. The PAIRSCAN allows a genome-wide search for epistasis. For PAIRSCAN, we tested the combined (or full model) effects on trait of a marker pair, which reflects the main effects of both markers plus their interaction (38). The threshold for genome-wide significance was set at 5%, which was estimated by a 200-permutation test carried out on F2 data.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Serum lipoprotein cholesterol profiles of MRL, SJL, F1, and F2 intercross mice
The fat mass calculated as percent body weight was 38% (P < 0.001) higher in MRL mice as compared with SJL mice (Table 1). The MRL mice had 60% (P < 0.001) higher body weight as compared with SJL mice (details not shown). However, there was a moderate but highly significant correlation between percent fat mass and body weight (Pearson r value = 0.25; P < 0.001), indicating that about 6.2% of the body weight was explained by variance in percent fat mass. Serum concentrations of cholesterol and HDL were higher in MRL mice by 82% (P < 0.001), and 120% (P < 0.001), respectively, as compared with SJL mice (Table 1). The TG levels were 58% (P < 0.001) higher in SJL mice compared with MRL mice. The percent fat mass, cholesterol, and HDL levels were intermediate (Table 1) and significantly different in F1 mice (P < 0.01 by ANOVA) compared with those of the parental strains. These data suggest that high cholesterol, HDL, and fat mass were inherited in an additive manner. The TG levels in F1 mice were significantly higher than in MRL mice but comparable to those of SJL mice (P > 0.05 by ANOVA), suggesting that TG levels were inherited in a dominant fashion (Table 1).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Percent body fat mass and lipid levels in standard diet-fed female MRL/MpJ and SJL/J mice

 
The distributions of fat mass, cholesterol, HDL, and TG among standard diet-fed female F2 mice are shown in Fig. 1A, C, E, G. The distributions of fat mass did not pass the normality test (Shapiro WilkW = 0.9; P < 0.05; n = 621; mean ± SD, 12.9 ± 3.1). As expected for mice fed a standard diet, there was a highly significant correlation between cholesterol and HDL levels in the F2 mice (n = 518; Pearson correlation coefficient, r = 0.96; P < 0.0001). The distributions of cholesterol (mean ± SD, 133 ± 27 mg/dl), HDL (mean ± SD, 112 ± 25 mg/dl), and TG (mean ± SD, 207 ± 75 mg/dl) were continuous (Fig. 1C, E, G) but did not pass the normality test (Shapiro Wilk W = 0.95–0.98; P < 0.01). However, the range of F2 values exceeded mean ± 2 SD parental intervals for each trait. The correlation between fat mass and lipid levels was very weak (Pearson r values 0.006, 0.021, 0.05 for HDL, cholesterol, and TG) and nonsignificant (P > 0.05). Cholesterol levels showed a highly significant correlation with TG (Pearson r = 0.34; P < 0.0001). Taken together, these data also suggest a complex inheritance of serum lipid levels and fat mass in this cross.


Figure 1
View larger version (45K):
[in this window]
[in a new window]
  		Fig. 1. Genome-wide linkage map of percent fat mass in MRL x SJL F2 female mice. A, C, E, and G: Distribution of percent fat mass, cholesterol, HDL cholesterol, and triglyceride (TG) in MRL x SJL female F2 mice (n = 518–621). B, D, F, H: Linkage maps of percent fat mass, cholesterol, HDL cholesterol, and TG in MRL x SJL female F2 mice. Solid horizontal lines in B, D, F, and H indicate the threshold for genome-wide significance for P < 0.01. Broken horizontal lines in B, D, F, and H indicate the threshold for genome-wide significance for P < 0.05.

 
Identification of genetic loci affecting obesity or body fat mass
The linkage map for body fat mass was constructed using a panel of 621 MRL x SJL F2 mice. Two significant QTLs were identified on chromosomes 11 and 16 (Fig. 1B), with strongest linkage (LOD score 11) on chromosome 11 (Table 2). Because single-marker D16Mit51 indicated the linkage on chromosome 16, mapping of D16Mit51 should be considered provisional; the locus is located at the end of a chromosome and confirmatory polymorphic markers flanking the linked marker (D16Mit51) could not be identified. A suggestive QTL was identified on chromosome 7 at 50 cM with an LOD score of 2.4 (genome-wide significance; P < 0.68). In addition, we observed a QTL on chromosome 1 at 82 cM linked to the marker D1Mit33 with an LOD score of 6.6 (P < 0.0001); however, this QTL was not supported by flanking markers, and hence was excluded from any further analysis. Figure 2 shows posterior probability plots, likelihood statistics that give rise to the 95% confidence interval for a locus. Taken together, the three QTLs (excluding chromosome 1 QTL) explained approximately 18% of the phenotypic variance in F2 female mice. We also calculated LOD scores for the BMI trait, which failed to pass the threshold of significance for suggestive linkage (P < 0.63) for any loci (data not shown), indicating that linkage of fat mass was largely independent of BMI in this cross.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Major QTLs that influence body fat mass and lipid levels in standard diet-fed female MRL/MpJ and SJL/J mice

 

Figure 2
View larger version (25K):
[in this window]
[in a new window]
  		Fig. 2. A, B: Logarithm of the odds ratio (LOD) score and posterior probability density plots for the major quantitative trait loci (QTLs) influencing percent fat mass. C, D: Allelic contribution of closest marker located on major QTL peak. MRL/MRL represents homozygosity for MRL/MpJ alleles; SJL/SJL represents homozygosity for SJL/J alleles; and heterozygosity at a locus is represented by MRL/SJL. Chromosome 11 was analyzed using five markers, and chromosome 16 was analyzed using three markers. Locations of these markers are shown as vertical lines on the x axis. Posterior probability density is a likelihood statistic that gives rise to the 95% confidence intervals indicated by black horizontal bars. Error bars represent SEM. a = P < 0.05 vs SJL/SJL; b = P < 0.05 vs MRL/SJL (by ANOVA). Chr, chromosome; cM, centimorgan.

 
Localization of cholesterol, HDL, and TG QTLs
The linkage maps for lipids were generated using a panel of 518 (MRL x SJL) F2 mice for which blood was available. The results of interval mapping of these traits are shown in Table 2 and Fig. 1. Five statistically significant cholesterol QTLs were identified on chromosomes 1, 3, 5, 7, and 17 (the three strongest linkages are shown in Fig. 3). The highest LOD score was observed for the chromosome 1 locus, with peak LOD score of 22 at D1Mit453 (Fig. 3). As expected for mice fed a standard diet, the HDL loci were coincident with loci underlying cholesterol levels, but only three QTLs on chromosomes 1, 3, and 5 reached the threshold of genome-wide significance (shown in Figs. 3, 4 along with the alleles contributing to closest peak marker). The QTL on chromosome 1 exerted the strongest effect on cholesterol and HDL, explain ing 28% and 30%, respectively, of the variance (Table 2) in F2 mice. Significant linkage for TG was observed on two loci on chromosomes 1 and 12 (Fig. 5). Two suggestive linkages were observed for TG on chromosomes 5 and 17 (Table 2).


Figure 3
View larger version (31K):
[in this window]
[in a new window]
  		Fig. 3. A, C, E: LOD score and posterior probability density plots for the major QTLs influencing cholesterol. B, D, F: Allelic contribution of closest marker located on major QTL peak. MRL/MRL represents homozygosity for MRL/MpJ alleles; SJL/SJL represents homozygosity for SJL/J alleles; and heterozygosity at a locus is represented by MRL/SJL. Chromosome 1 was analyzed using 22 markers, chromosome 3 was analyzed using 5 markers, and chromosome 7 was analyzed using 7 markers. Locations of these markers are shown as vertical lines on the x axis. Posterior probability density is a likelihood statistic that gives rise to the 95% confidence intervals indicated by the black horizontal bars. Error bars represent SEM. a = P < 0.05 vs SJL/SJL; b = P < 0.05 vs MRL/SJL (by ANOVA). Chr, chromosome; cM, centimorgan; PPD, posterior probability density.

 

Figure 4
View larger version (31K):
[in this window]
[in a new window]
  		Fig. 4. A, C, E: LOD score and posterior probability density plots for the major QTLs influencing HDL. B, D, F: Allelic contribution of closest marker located on major QTL peak. MRL/MRL represents homozygosity for MRL/MpJ alleles; SJL/SJL represents homozygosity for SJL/J alleles; and heterozygosity at a locus is represented by MRL/SJL. Chromosome 1 was analyzed using 22 markers; chromosomes 3 and 5 were analyzed using 5 markers each. Locations of these markers are shown as vertical lines on the x axis. Error bars represent SEM. Posterior probability density is a likelihood statistic that gives rise to the 95% confidence intervals indicated by the black horizontal bars. a = P < 0.05 vs SJL/SJL; b = P < 0.05 vs MRL/SJL (by ANOVA). Chr, chromosome; cM, centimorgan.

 

Figure 5
View larger version (29K):
[in this window]
[in a new window]
  		Fig. 5. A, C: LOD score and posterior probability density plots for the major QTLs influencing TG . B, D: Allelic contribution of closest marker located on major QTL peak. MRL/MRL represents homozygosity for MRL/MpJ alleles; SJL/SJL represents homozygosity for SJL/J alleles; and heterozygosity at a locus is represented by MRL/SJL. Chromosome 1 was analyzed using 22 markers, and chromosome 12 was analyzed using 8 markers. Locations of these markers are shown as vertical lines on the x axis. Error bars represent SEM. Posterior probability density is a likelihood statistic that gives rise to the 95% confidence intervals indicated by the black horizontal bars. a = P < 0.05 vs SJL/SJL; c = P < 0.05 vs MRL/MRL and SJL/SJL (by ANOVA). Chr, chromosome; cM, centimorgan.

 
The LOD scores for cholesterol were comparable to analogous scores for HDL levels at chromosomes 1, 3, and 5 QTLs, whereas LOD scores for cholesterol and HDL for chromosomes 7 and 17 appear to be differentially regulated, suggesting additional QTL(s) that may regulate non-HDL cholesterol levels. To investigate this further, we performed linkage analysis using non-HDL cholesterol levels (calculated by subtracting HDL from total cholesterol) in female F2 mice (Table 2). Linkage to non-HDL cholesterol was detected in F2 mice on chromosome 7 (D7Mit76), accounting for 4.0% variance. Additional linkages were observed for chromosome 12 (D12Mit182), accounting for 6.2% variance, and chromosome 9 (D9Mit208), accounting for 3.0% variance (inherited in an additive manner; data not shown). The peaks on chromosome 7 and chromosome 17 were coincident with the peaks for cholesterol and HDL levels (Table 2). Although the above data provide genetic evidence for differential regulation of non-HDL cholesterol, however, the results on non-HDL cholesterol should be interpreted cautiously because the blood levels of non-HDL cholesterol are very low.

Nonparametric mapping with the Kruskal-Wallis Test to assess fat mass and lipid QTLs
The interval-mapping approach for QTL analysis is based on the assumption that the residual environmental variation follows a normal distribution. However, the fat mass and lipid data showed slight deviation from normal distribution. Therefore, the Kruskal-Wallis rank sum test, which makes no assumptions about the probability distributions of the phenotypic data, was also employed to determine trait-marker association. The Kruskal-Wallis analysis, performed with fat mass and serum lipid level phenotype data in the MapQTL program, confirmed all loci identified by interval mapping. The Kruskal-Wallis K values ranged between 15 and 90 for different loci; most importantly, the significance level for all significant loci identified by interval mapping was P < 0.001 (Table 2).

Allelic variation for QTLs affecting lipid levels and body fat mass
At the peaks of linkage for cholesterol, HDL, TG, and fat mass, the genotypic means in F2s, represented by the closest markers, were calculated for F2 females and are shown in Figs. 2–5. For fat mass locus on chromosome 11, the homozygotes for the MRL allele had 21.3% (P < 0.0001) higher fat mass, as compared with the homozygotes for the SJL allele. At the chromosome 7 locus, the mean fat mass for the homozygous MRL and SJL alleles were 5–8% lower than that of heterozygotes (data not shown). For the loci on chromosome 16, homozygotes for the SJL allele had 8.7% (P < 0.05) higher fat mass than the homozygotes for the MRL allele. At the chromosome 11 locus, the phenotypic effect of the MRL allele best fit an additive model, whereas for the chromosome 16 locus, the phenotypic effect of the SJL allele best fit a recessive mode of inheritance.

For cholesterol and HDL, the phenotypic effects of the MRL allele at loci on chromosomes 1, 3, 5, 7, and 17 are inherited in an additive manner. For cholesterol, HDL, and TG, the loci on chromosome 1 of the MRL allele were 27, 31, and 19%, respectively (all P < 0.001), higher than the those of the homozygotes for the SJL allele. For the locus on chromosome 14, the homozygous SJL alleles have 9% higher cholesterol and HDL levels as compared with MRL homozygotes (details not shown). At the locus on chromosome 12 for TG, homozygotes for the SJL allele had 19.2% (P < 0.001) higher TG levels than the homozygotes for the MRL allele, and the SJL allele are inherited in an additive manner.

Although the fat mass, cholesterol, and HDL levels were higher in the MRL strain, it is noteworthy that recessive SJL alleles at chromosome 16 increased fat mass (Fig. 2), and a dominant chromosome 14 SJL allele increased HDL and cholesterol levels (data not shown). Similarly, parental SJL strains have higher TG levels than do parental MRL strains, yet QTL analysis in the F2s revealed that dominant MRL alleles at chromosome 1 increase TG levels (Fig. 5). This type of finding has been observed in other QTL analyses (39), and presumably means that the MRL or SJL alleles at these loci are phenotypically silent (39) in the context of the MRL and SJL genomes, respectively, but the increase fat mass or lipid levels in the presence of one or more SJL alleles.

QTL-QTL interactions
Two loci showed interactions when the genotype at one locus affected the effect of the other locus. However, the LOD scores for all locus interactions, determined using the Pseudomarker PAIRSCAN software program, were suggestive in nature (data not shown).

Pleiotropic effects on fat mass and lipid levels
Our results show that the two loci on chromosome 1 and chromosome 11 have pleiotropic effects on multiple phenotypes. The chromosome 1 locus at 82 cM has a pleiotropic effect on cholesterol, HDL, and TG levels. In addition to phenotypes described in this study, we have also obtained QTLs for body weight, body length, and several musculoskeletal phenotypes (33–36). Interestingly, loci on chromosome 1 and chromosome 11 showed concordance with QTLs that regulate some skeletal phenotypes. The chromosome 1 locus (D1Mit33) was concordant with the total body bone density and volumetric bone density at tibia midshaft described previously in the same F2 female mice (35). The chromosome 11 locus (D11Mit36) was concordant with QTLs identified for fat mass, body weight, muscle mass, and body length (QTLs for these phenotypes have been described previously) (33). In addition, the chromosome 11 locus showed concordance with the QTL that affects radial bone size (periosteal circumference at midshaft tibia).

To investigate how lipid QTLs affect fat mass, we compared the genotype influence of loci (D11Mit36 and D16Mit51) that regulate fat mass in a subset of female F2 mice grouped by genotype of loci that regulate cholesterol and HDL (D1Mit453, D3Mit217, D7Mit246, D5Mit136, and D12Mit201). Genotype groups that showed significant differences (by ANOVA) between homozygous MRL and SJL alleles are shown in Fig. 6. For genotype D1Mit453, F2 mice homozygous for the MRL-derived allele for D11Mit36 (Fig. 6A) exhibited 7% higher fat mass (P < 0.05 by ANOVA), as compared with those derived from homozygous SJL alleles. For genotype D1Mit453, F2 mice homozygous for the SJL-derived allele for D16Mit51 (Fig. 6B) exhibited 10% higher fat mass (P < 0.05 by ANOVA) as compared with those derived from homozygous MRL alleles. For female F2 mice grouped by genotype for D1Mit453, F2 mice homozygous for the SJL-derived allele for genotype D12Mit201 exhibited 20–28% higher levels of TG (P < 0.05) as compared to those derived from homozygous MRL alleles (Fig. 6C). The relative effects of D1Mit453 alleles on fat mass among the F2 mice indicate that locus D1Mit453, in addition to regulating cholesterol and HDL levels, represents an important determinant of the fat mass variation between the MRL and SJL strains. Taken together, these data suggest that the genes underlying loci of chromosomes 1, 11, 12, and 16 could play critical roles in determining both fat mass and lipid levels.


Figure 6
View larger version (24K):
[in this window]
[in a new window]
  		Fig. 6. A, B: Genotypic influence of three loci (D11Mit36 and D16Mit51) regulating fat mass in a subset of female F2 mice grouped by genotype of locus (D1Mit453) regulating blood cholesterol and HDL levels. C: Genotypic influence of locus (D12Mit201) regulating TG in a subset of female F2 mice grouped by genotype at locus (D1Mit453) regulating cholesterol. Data points and error bars represent mean ± SEM.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The genome-wide scans of MRL x SJL F2 mice for associations between marker genotypes and the quantitative phenotypes of total body fat mass and serum lipid levels resulted in the localization of several novel QTLs, particularly for percent fat mass and TG levels. Fat mass has a significant heritability (40) and previous studies have identified >20 loci (Table 3) that regulate total body fat mass (12, 14, 17, 26, 40–44). However, only two major loci, located on chromosome 2 (17) and chromosome 8 (14) have been concordant in more than one cross. A body fat QTL identified on chromosome 2 in NZB/BINJ x SM/J mice (17) was concordant with a QTL in a C57BL/6J x CAST/Ei (29) cross. The region of chromosome 2 QTL in these two crosses is syntenic with a large region of human chromosome 20, which shows linkage to body fat mass. Recently Ishimori et al. (14) have shown a locus on chromosome 8 in the C57Bl/6J x 129S1/SvlmJ cross that regulates fat mass similar to that identified previously in the C57Bl/6J x CAST/Ei cross (29). These findings suggest that the full repertoire of QTLs affecting fat mass has not yet been determined and that identification of candidate genes that regulate obesity is still in its early phase. QTLs observed in this study account for approximately 18% of the total variance in percent fat mass in F2 mice. The lower estimates of total F2 variance explained by the loci identified in this study could be due to the presence of QTLs that have a small effect on F2 variance and hence are difficult to identify. In addition, the best estimate of total variance explained is obtained by identifying plieotropic interactions, which is a challenging task because of lower power to detect such interactions. We did not observe any significant interaction, which may partly explain the lower variance explained by the loci identified in this study. Taken together, our results and published findings indicate that results from several F2 crosses may be necessary for identifying the majority of QTLs that affect fat mass. Out of three loci (chromosomes 7, 11, and 16) that regulate body fat mass, two QTLs on chromosomes 11 and 16 were specific to the MRL x SJL cross. Previous data published by our laboratory on the MRL x SJL F2 mice (33) indicated that the chromosome 7 (LOD 2.4) locus was colocalized with a locus that regulates lean body mass (5.5 cM, LOD 2.9). In addition, the locus on chromosome 11 colocalizes with QTLs that regulate body weight, muscle mass, body length, and radial bone size. It could be speculated that the effect of the chromosome 11 locus on radial bone size is indirectly related to bone adaptive response to mechanical loading resulting from higher body weight. In mice, the major effect of mechanical loading is reflected in an increase in the periosteal perimeter of long bones. It is noteworthy that there was a significant correlation between body weight and percent fat mass (r = 0.25; P < 0.0001), indicating that the same gene(s) may regulate these phenotypes. Together, these findings suggest that the chromosome 7 and chromosome 11 loci that regulate fat mass have pleiotropic effects on body weight. It remains to be verified whether the same gene or independent genes under these loci regulate the multiple phenotypes.


View this table:
[in this window]
[in a new window]
  		TABLE 3. Body fat mass or obesity QTLs detected in female mice in various genetic crosses

 
Several candidate genes have been identified for all fat mass loci. The prominent candidates for the chromosome 11 locus includeNos2 (nitric oxide synthase 2), Hcrt (hypocretin), Alox12, Alox3, Alox15, Alox12b, and Alox12e (all belong to a family of lipoxygenases that are a class of iron-containing dioxygenases that catalyze the hydroperoxidation of lipids), and Lpd1, a mouse insertional mutation lpd (lipid defect) whose phenotype includes elevated plasma TG (45) and is a potential candidate gene for the chromosome 16 QTL. Although the above-mentioned genes are obvious candidates, on the basis of their known functions, ultimately, identification of the gene(s) underlying a particular QTL will be necessary for determining which subset of genes contributes to the genetic variation of a trait across species.

Previous linkage studies have identified >20 loci regulating TG on chromosomes 4, 8, 9, 11, 12, 14, 18, and 19 (as shown in Table 4). However, only two loci on chromosome 2 and chromosome 8 have been colocalized in multiple crosses. In this study, four loci on chromosomes 1, 5, 12, and 17 were in linkage with serum levels of TGs. The chromosome 12 QTL (at 25 cM) identified in this study does not appear to be concordant with any previously known QTL on chromosome 12, which showed a peak at 39 cM. Therefore, the majority of TG QTLs identified in the MRL x SJL cross appear to be novel. The QTL on chromosome 12, however, incorporates QTLs identified earlier for fat mass (at 29 cM) (46) and HDL (at 17.2 cM) (31) in mice. For non-HDL cholesterol, the locus identified in this study on chromosome 7 was concordant with the cholesterol and HDL locus, suggesting that the candidate gene in this region may regulate both HDL and non-HDL cholesterol. The chromosome 12 locus was proximal to the TG QTL located on chromosome 12 and could independently regulate non-HDL cholesterol. The locus on chromosome 9 appears to be novel for non-HDL cholesterol. The TG QTLs identified in this study have a limitation in that the blood samples were collected under nonfasting conditions and some of the QTLs could be influenced by nongenetic factors.


View this table:
[in this window]
[in a new window]
  		TABLE 4. QTLs affecting triglyceride levels in various genetic crosses

 
QTLs on chromosomes 1, 3, 5, 7, and 17 (14, 30, 31) that regulate HDL and cholesterol levels are concordant with linkages previously identified in standard diet-fed F2 mice. Location and peaks of all the loci identified in this study, with the exception of the chromosome 14 locus, coincide with published HDL cholesterol peaks. These findings confirm the belief that, in general, we may have reached saturation as far as identification of HDL and cholesterol QTLs are concerned. Results of this study show that almost 70% (Table 2) of the total variance in cholesterol levels in F2 mice was explained by the QTLs identified in this study. The strongest linkage for cholesterol was identified on chromosome 1 in MRL x SJL F2 mice. This chromosome 1 locus contains the apolipoprotein A-II (apoA-II) gene, which has polymorphism that has been implicated as an HDL QTL gene in seven different crosses (47). The MRL strain carries the APOA2b haplotype allele (47) known to impart higher HDL levels, whereas the SJL strain carries the apoA-IIc allele, which is responsible for lower HDL levels. However, a high LOD score of 21–24 for two distinct peaks may indicate the possible involvement of other unknown gene(s) present in this region. The chromosome 14 locus observed in this study, although suggestive in nature, was located in the distal region of any known chromosome 14 QTL (30, 31) and therefore could represent a distinct linkage finding. Several candidate genes for cholesterol and HDL have been located within the QTL regions identified in this study. A comprehensive list of these genes is available in a recently published review (31).

Identifying the gene underlying a QTL is a complex task; therefore, the process of identifying genes for QTLs discovered to date has been slow. Recently it was shown that single-nucleotide polymorphisms (SNPs) can be used to narrow a QTL, because gene(s) underlying a QTL should be in the region where the parental strains have a haplotype divergence (47–49). Consequently, haplotype analysis of the chromosome 1 QTL (confirmed in multiple crosses) led to identification of a polymorphism in the Apoa2 gene that affected HDL levels (47). In this regard, our findings on HDL and cholesterol QTLs could be important for future research directed toward the search for genes that regulate lipid levels. Results from each analysis were compared on the assumption that more common variants would be detected more frequently across the strains and that the QTL genes that are detected in these multiple crosses could be discovered quickly by analyzing their SNPs and haplotypes in multiple strains. The inferred haplotype data may also facilitate the refinement of QTL regions, such that candidate genes can be more easily identified and characterized.

In summary, we have identified several distinct linkages for TG and body fat mass and have confirmed the loci that regulate HDL and cholesterol that were identified in previous genetic crosses. The presence of similar QTLs in previous crosses suggests that for some genes, there are higher degrees of polymorphism. On the other hand, identification of novel loci may indicate the presence of additional genes or modifier genes that regulate a given trait. Thus, our data contribute to the growing knowledge of the genetic complexity of lipid metabolism and obesity and also underscore the importance of strain background in the evaluation of the linkage for a complex trait. It is hoped that the discovery of genes at these loci may help in explaining the variability in lipid levels in humans.


   ACKNOWLEDGMENTS
 
This work was supported by Army Assistance Award DAMD17-99-1-9571. The U.S. Army Medical Research Acquisition Activity (Fort Detrick, MD) 21702-5014 is the awarding and administering acquisition office for the DAMD award. The information contained in this article does not necessarily reflect the position or the policy of the U.S. government, and no official endorsement should be inferred. All work was performed in facilities provided by the Department of Veterans Affairs.

Manuscript received July 11, 2005 and in revised form September 21, 2005 and in re-revised form October 26, 2005.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
  1. Kannel, W., W. Castelli, T. Gordon, and P. McNamara. 1971. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study. Ann. Intern. Med. 74: 1–12.[Medline]

  2. North, K. E., B. V. Howard, T. K. Welty, L. G. Best, E. T. Lee, J. L. Yeh, R. R. Fabsitz, M. J. Roman, and J. W. MacCluer. 2003. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am. J. Epidemiol. 157: 303–314.[Abstract/Free Full Text]

  3. Breslow, J. I. 1996. Battling heart disease. Science. 273: 15.[Free Full Text]

  4. Brousseau, T., A. M. Dupuy-Gorce, A. Evans, D. Arveiler, J. B. Ruidavets, B. Haas, J. P. Cambou, G. Luc, P. Ducimetiere, P. Amouyel, and N. Helbecque. 2002. Significant impact of the highly informative (CA)n repeat polymorphism of the APOA-II gene on the plasma APOA-II concentrations and HDL subfractions: the ECTIM study. Am. J. Med. Genet. 110: 19–24.[CrossRef][Medline]

  5. Brown, M. S., and J. L. Goldstein. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89: 331–340.[CrossRef][Medline]

  6. Bu, X., C. H. Warden, Y. R. Xia, C. De Meester, D. L. Puppione, S. Teruya, B. Lokensgard, S. Daneshmand, J. Brown, R. J. Gray, et al. 1994. Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum. Genet. 93: 639–648.[Medline]

  7. Cases, S., S. J. Smith, Y. W. Zheng, H. M. Myers, S. R. Lear, E. Sande, S. Novak, C. Collins, C. B. Welch, A. J. Lusis, et al. 1998. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. USA. 95: 13018–13023.[Abstract/Free Full Text]

  8. Wang, X., M. Ria, P. M. Kelmenson, P. Eriksson, D. C. Higgins, A. Samnegard, C. Petros, J. Rollins, A. M. Bennet, B. Wiman, et al. 2005. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat. Genet. 37: 365–372.[CrossRef][Medline]

  9. Castellani, L. W., A. Weinreb, J. Bodnar, A. M. Goto, M. Doolittle, M. Mehrabian, P. Demant, and A. J. Lusis. 1998. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat. Genet. 18: 374–377.[CrossRef][Medline]

  10. Anunciado, R. V., M. Nishimura, M. Mori, A. Ishikawa, S. Tanaka, F. Horio, T. Ohno, and T. Namikawa. 2003. Quantitative trait locus analysis of serum insulin, triglyceride, total cholesterol and phospholipid levels in the (SM/J x A/J)F2 mice. Exp. Anim. 52: 37–42.[CrossRef][Medline]

  11. Anunciado, R. V., T. Ohno, M. Mori, A. Ishikawa, S. Tanaka, F. Horio, M. Nishimura, and T. Namikawa. 2000. Distribution of body weight, blood insulin and lipid levels in the SMXA recombinant inbred strains and the QTL analysis. Exp. Anim. 49: 217–224.[CrossRef][Medline]

  12. Taylor, B. A., and S. J. Phillips. 1997. Obesity QTLs on mouse chromosomes 2 and 17. Genomics. 43: 249–257.[CrossRef][Medline]

  13. Gu, L., A. Weinreb, X. P. Wang, D. J. Zack, J. H. Qiao, R. Weisbart, and A. J. Lusis. 1998. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J. Immunol. 161: 6999–7006.[Abstract/Free Full Text]

  14. Ishimori, N., R. Li, P. M. Kelmenson, R. Korstanje, K. A. Walsh, G. A. Churchill, K. Forsman-Semb, and B. Paigen. 2004. Quantitative trait loci that determine plasma lipids and obesity in C57BL/6J and 129S1/SvImJ inbred mice. J. Lipid Res. 45: 1624–1632.[Abstract/Free Full Text]

  15. Korstanje, R., J. J. Albers, G. Wolfbauer, R. Li, A. Y. Tu, G. A. Churchill, and B. J. Paigen. 2004. Quantitative trait locus mapping of genes that regulate phospholipid transfer activity in SM/J and NZB/BlNJ inbred mice. Arterioscler. Thromb. Vasc. Biol. 24: 155–160.[Abstract/Free Full Text]

  16. Korstanje, R., R. Li, T. Howard, P. Kelmenson, J. Marshall, B. Paigen, and G. Churchill. 2004. Influence of sex and diet on quantitative trait loci for HDL cholesterol levels in an SM/J by NZB/BlNJ intercross population. J. Lipid Res. 45: 881–888.[Abstract/Free Full Text]

  17. Lembertas, A. V., L. Perusse, Y. C. Chagnon, J. S. Fisler, C. H. Warden, D. A. Purcell-Huynh, F. T. Dionne, J. Gagnon, A. Nadeau, A. J. Lusis, et al. 1997. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J. Clin. Invest. 100: 1240–1247.[Medline]

  18. Lyons, M. A., R. Korstanje, R. Li, K. A. Walsh, G. A. Churchill, M. C. Carey, and B. Paigen. 2004. Genetic contributors to lipoprotein cholesterol levels in an intercross of 129S1/SvImJ and RIIIS/J inbred mice. Physiol. Genomics. 17: 114–121.[Abstract/Free Full Text]

  19. Lyons, M. A., H. Wittenburg, R. Li, K. A. Walsh, G. A. Churchill, M. C. Carey, and B. Paigen. 2003. Quantitative trait loci that determine lipoprotein cholesterol levels in DBA/2J and CAST/Ei inbred mice. J. Lipid Res. 44: 953–967.[Abstract/Free Full Text]

  20. Lyons, M. A., H. Wittenburg, R. Li, K. A. Walsh, R. Korstanje, G. A. Churchill, M. C. Carey, and B. Paigen. 2004. Quantitative trait loci that determine lipoprotein cholesterol levels in an intercross of 129S1/SvImJ and CAST/Ei inbred mice. Physiol. Genomics. 17: 60–68.[Abstract/Free Full Text]

  21. Gu, L., M. W. Johnson, and A. J. Lusis. 1999. Quantitative trait locus analysis of plasma lipoprotein levels in an autoimmune mouse model: interactions between lipoprotein metabolism, autoimmune disease, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 19: 442–453.[Abstract/Free Full Text]

  22. Diament, A. L., P. Farahani, S. Chiu, J. Fisler, and C. H. Warden. 2004. A novel mouse chromosomeomosome 2 congenic strain with obesity phenotypes. Mamm. Genome. 15: 452–459.[CrossRef][Medline]

  23. Mu, J. L., J. K. Naggert, K. L. Svenson, G. B. Collin, J. H. Kim, C. McFarland, P. M. Nishina, D. M. Levine, K. J. Williams, and B. Paigen. 1999. Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J. J. Lipid Res. 40: 1328–1335.[Abstract/Free Full Text]

  24. Paigen, B., N. J. Schork, K. L. Svenson, Y. C. Cheah, J. L. Mu, F. Lammert, D. Q. Wang, G. Bouchard, and M. C. Carey. 2000. Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice. Physiol. Genomics. 4: 59–65.[Abstract/Free Full Text]

  25. Pitman, W. A., R. Korstanje, G. A. Churchill, E. Nicodeme, J. J. Albers, M. C. Cheung, M. A. Staton, S. S. Sampson, S. Harris, and B. Paigen. 2002. Quantitative trait locus mapping of genes that regulate HDL cholesterol in SM/J and NZB/B1NJ inbred mice. Physiol. Genomics. 9: 93–102.[Abstract/Free Full Text]

  26. Singer, J. B., A. E. Hill, L. C. Burrage, K. R. Olszens, J. Song, M. Justice, W. E. O'Brien, D. V. Conti, J. S. Witte, E. S. Lander, et al. 2004. Genetic dissection of complex traits with chromosome substitution strains of mice. Science. 304: 445–448.[Abstract/Free Full Text]

  27. Suto, J., and K. Sekikawa. 2003. Quantitative trait locus analysis of plasma cholesterol and triglyceride levels in KK x RR F2 mice. Biochem. Genet. 41: 325–341.[CrossRef][Medline]

  28. Suto, J., Y. Takahashi, and K. Sekikawa. 2004. Quantitative trait locus analysis of plasma cholesterol and triglyceride levels in C57BL/6J x RR F2 mice. Biochem. Genet. 42: 347–363.[CrossRef][Medline]

  29. York, B., K. Lei, and D. B. West. 1996. Sensitivity to dietary obesity linked to a locus on chromosome 15 in a CAST/Ei x C57BL/6J F2 intercross. Mamm. Genome. 7: 677–681.[CrossRef][Medline]

  30. Wang, X., and B. Paigen. 2005. Genetics of variation in HDL cholesterol in humans and mice. Circ. Res. 96: 27–42.[Abstract/Free Full Text]

  31. Wang, X., and B. Paigen. 2002. Quantitative trait loci and candidate genes regulating HDL cholesterol: a murine chromosome map. Arterioscler. Thromb. Vasc. Biol. 22: 1390–1401.

  32. Masinde, G. L., X. Li, W. Gu, H. Davidson, S. Mohan, and D. J. Baylink. 2001. Identification of wound healing/regeneration quantitative trait loci (QTL) at multiple time points that explain seventy percent of variance in (MRL/MpJ and SJL/J) mice F2 population. Genome Res. 11: 2027–2033.[Abstract/Free Full Text]

  33. Masinde, G. L., X. Li, W. Gu, H. Davidson, M. Hamilton-Ulland, J. Wergedal, S. Mohan, and D. J. Baylink. 2002. Quantitative trait loci (QTL) for lean body mass and body length in MRL/MPJ and SJL/J F(2) mice. Funct. Integr. Genomics. 2: 98–104.

  34. Masinde, G. L., X. Li, W. Gu, J. Wergedal, S. Mohan, and D. J. Baylink. 2002. Quantitative trait loci for bone density in mice: the genes determining total skeletal density and femur density show little overlap in F2 mice. Calcif. Tissue Int. 71: 421–428.[CrossRef][Medline]

  35. Masinde, G. L., X. Li, W. Gu, M. Hamilton-Ulland, S. Mohan, and D. J. Baylink. 2002. Quantitative trait loci that harbor genes regulating muscle size in (MRL/MPJ x SJL/J) F(2) mice. Funct. Integr. Genomics. 2: 120–125.[CrossRef][Medline]

  36. Masinde, G. L., J. Wergedal, H. Davidson, S. Mohan, R. Li, X. Li, and D. J. Baylink. 2003. Quantitative trait loci for periosteal circumference (PC): identification of single loci and epistatic effects in F2 MRL/SJL mice. Bone. 32: 554–560.[Medline]

  37. Srivastava, A. K., G. Masinde, H. Yu, D. J. Baylink, and S. Mohan. 2004. Mapping quantitative trait loci that influence blood levels of alkaline phosphatase in MRL/MpJ and SJL/J mice. Bone. 35: 1086–1094.[Medline]

  38. Sugiyama, F., G. A. Churchill, D. C. Higgins, C. Johns, K. P. Makaritsis, H. Gavras, and B. Paigen. 2001. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics. 71: 70–77.[CrossRef][Medline]

  39. Dansky, H. M., P. Shu, M. Donavan, J. Montagno, D. L. Nagle, J. S. Smutko, N. Roy, S. Whiteing, J. Barrios, T. J. McBride, et al. 2002. A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics. 160: 1599–1608.[Abstract/Free Full Text]

  40. Barsh, G. S., I. S. Farooqi, and S. O'Rahilly. 2000. Genetics of body-weight regulation. Nature. 404: 644–651.[Medline]

  41. Taylor, B. A., and S. J. Phillips. 1996. Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics. 34: 389–398.[CrossRef][Medline]

  42. Taylor, B. A., L. M. Tarantino, and S. J. Phillips. 1999. Gender-influenced obesity QTLs identified in a cross involving the KK type II diabetes-prone mouse strain. Mamm. Genome. 10: 963–968.[CrossRef][Medline]

  43. Mehrabian, M., P. Z. Wen, J. Fisler, R. C. Davis, and A. J. Lusis. 1998. Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J. Clin. Invest. 101: 2485–2496.[Medline]

  44. Warden, C. H., J. S. Fisler, S. M. Shoemaker, P. Z. Wen, K. L. Svenson, M. J. Pace, and A. J. Lusis. 1995. Identification of four chromosomal loci determining obesity in a multifactorial mouse model. J. Clin. Invest. 95: 1545–1552.[Medline]

  45. Wen, X. Y., R. A. Hegele, J. Wang, D. Y. Wang, J. Cheung, M. Wilson, M. Yahyapour, Y. Bai, L. Zhuang, J. Skaug, et al. 2003. Identification of a novel lipase gene mutated in lpd mice with hypertriglyceridemia and associated with dyslipidemia in humans. Hum. Mol. Genet. 12: 1131–1143.[Abstract/Free Full Text]

  46. Brockmann, G. A., J. Kratzsch, C. S. Haley, U. Renne, M. Schwerin, and S. Karle. 2000. Single QTL effects, epistasis, and pleiotropy account for two-thirds of the phenotypic F(2) variance of growth and obesity in DU6i x DBA/2 mice. Genome Res. 10: 1941–1957.[Abstract/Free Full Text]

  47. Wang, X., R. Korstanje, D. Higgins, and B. Paigen. 2004. Haplotype analysis in multiple crosses to identify a QTL gene. Genome Res. 14: 1767–1772.[Abstract/Free Full Text]

  48. Park, Y. G., R. Clifford, K. H. Buetow, and K. W. Hunter. 2003. Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes. Genome Res. 13: 118–121.[Abstract/Free Full Text]

  49. Manenti, G., F. Galbiati, R. Gianni-Barrera, A. Pettinicchio, A. Acevedo, and T. A. Dragani. 2004. Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice. Oncogene. 23: 4495–4504.[CrossRef][Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
J. E. Wergedal, C. L. Ackert-Bicknell, W. G. Beamer, S. Mohan, D. J. Baylink, and A. K. Srivastava
Mapping genetic loci that regulate lipid levels in a NZB/B1NJxRF/J intercross and a combined intercross involving NZB/B1NJ, RF/J, MRL/MpJ, and SJL/J mouse strains
J. Lipid Res., August 1, 2007; 48(8): 1724 - 1734.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M500295-JLR200v1
47/1/123    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Srivastava, A. K.
Right arrow Articles by Baylink, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srivastava, A. K.
Right arrow Articles by Baylink, D. J.
Social Bookmarking